Gut microbiota and colorectal cancer metastasis.

[1]  Ling-Hui Li,et al.  Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer , 2022, Frontiers in Oncology.

[2]  G. Maulucci,et al.  Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells , 2022, Biomolecules.

[3]  C. Ni,et al.  High-Fat Diet Enhances the Liver Metastasis Potential of Colorectal Cancer through Microbiota Dysbiosis , 2022, Cancers.

[4]  Maria Pires Pacheco,et al.  The gut microbial metabolite formate exacerbates colorectal cancer progression , 2022, Nature Metabolism.

[5]  Tianhua Zhou,et al.  Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis , 2022, Nature Communications.

[6]  J. Si,et al.  Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis , 2022, Gut microbes.

[7]  Chaofan Liu,et al.  Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota , 2022, Aging.

[8]  Pengcheng Bu,et al.  Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell‐Like Features by Manipulating Lipid Droplet‐Mediated Numb Degradation , 2022, Advanced science.

[9]  Zhongxin Li,et al.  Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment , 2021, Gut and liver.

[10]  N. Segata,et al.  Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. , 2021, Cancer cell.

[11]  M. Mathonnet,et al.  The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials , 2021, Cancers.

[12]  D. Schrag,et al.  Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.

[13]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[14]  J. Si,et al.  Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization , 2021, Gut microbes.

[15]  Wan-Li Liu,et al.  Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16 , 2020, Gut.

[16]  Wei Jia,et al.  Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma , 2020, Protein & Cell.

[17]  Haresh Kumar Kantilal,et al.  The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation , 2020, The Malaysian journal of medical sciences : MJMS.

[18]  Qinyan Yang,et al.  Streptococcus bovis Contributes to the Development of Colorectal Cancer via Recruiting CD11b+TLR-4+ Cells , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[19]  B. Lambrecht,et al.  Zeb2 drives invasive and microbiota-dependent colon carcinoma , 2020, Nature Cancer.

[20]  Xujun Zhang,et al.  Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice , 2020, Cell Biology and Toxicology.

[21]  O. Mir,et al.  Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. , 2019, Pharmacology & therapeutics.

[22]  Tomoyoshi Soga,et al.  Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer , 2019, Nature Medicine.

[23]  A. Duval,et al.  Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status , 2019, JAMA oncology.

[24]  E. Le Chatelier,et al.  Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients , 2018, Science.

[25]  Donna Neuberg,et al.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.

[26]  J. Ket,et al.  Does severe toxicity affect global quality of life in patients with metastatic colorectal cancer during palliative systemic treatment? A systematic review , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  M. Huycke,et al.  Colorectal cancer: role of commensal bacteria and bystander effects , 2015, Gut microbes.

[28]  Jun Yu,et al.  Gut mucosal microbiome across stages of colorectal carcinogenesis , 2015, Nature Communications.

[29]  M. Huycke,et al.  Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect , 2014, Gut.

[30]  I. Nagtegaal,et al.  Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  S. Lightfoot,et al.  Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect. , 2013, Translational oncology.

[32]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[33]  A. van Dorsselaer,et al.  Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). , 2004, Carcinogenesis.